世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
世界的な出生数の増加に伴い、新生児スクリーニングの普及率が高まり、新生児メタボリックスクリーニングの全体的な市場を促進するWith global rising birth, the rising prevalence of new born screening propels the overall market for new-born metabolic screening 新生児メタボリックスクリーニングの世界市場。報告書の範囲 Persistence Market Research社の最新刊「新生児代謝スクリーニングの世界市場」は、機会や現在の市場展望を評価し、詳細な分析、市場に影響を与え... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー新生児メタボリックスクリーニングの世界市場。報告書の範囲Persistence Market Research社の最新刊「新生児代謝スクリーニングの世界市場」は、機会や現在の市場展望を評価し、詳細な分析、市場に影響を与える対応セクションに関する最新情報を提供しています。この調査は、市場の促進要因、抑制要因、動向、機会などを含む現在の市場力学に関する詳細な洞察を提供します。市場調査の主な目的は、市場が2022年から2032年の予測期間中にどのように実行されるかという排他的な情報を提示することです。 市場の成功成長のための重要な指標は、この包括的なレポートで提示されており、市場の前年比（YoY）成長分析、複合年間成長率（CAGR）など、Persistence Market Research社の調査において網羅的に記述されています。この調査研究は、世界の新生児メタボリックスクリーニングサービスの需要と調査期間中の定量的な発展機会を知るために読者をサポートすることができます。 この調査は、投資家、メーカー、サービスプロバイダー、流通業者、サプライヤーなどの景観の株主にとって有益であり、世界の新生児代謝スクリーニング市場で繁栄するための適切なビジネス戦略の開発に役立てることができます。このPersistence Market Researchの調査で示された洞察と情報は、新生児代謝スクリーニング市場の株主、業界専門家、投資家、研究者、記者、ビジネス愛好家が活用することができる。 市場統計、および新生児代謝スクリーニング市場のビジネスシナリオに影響を与えるマクロおよびミクロ経済変数に関連する情報も、現在の研究に含まれています。市場の潜在的な発展に応じて、実質的な洞察も本レポートで遭遇します。さらに、このレポートで提出されたデータによって、業界のマイナーな企業や新規参入者は、市場での牽引力を達成するために適切な会社の選択を行う際に支援されることができます。 主要な市場セグメント Persistence Market Research社の調査による、世界の新生児メタボリックスクリーニング市場は、テスト、サンプル、エンドユーザー、地域という4つの重要なセグメントに分けて情報を提供しています。本レポートは、これらのカテゴリに関連する重要な市場力学と成長パラメータに関する包括的なデータおよび情報を提供します。 検査 ガラクトース血症 鎌状赤血球症 嚢胞性線維症 トキソプラズマ症 フェニルケトン尿症(PKU) メチルマロン酸血症 メイプルシロップ尿症（MSUD） チロシン血症 シトルリン血症 中鎖アシルCoAデヒドロゲナーゼ(MCAD)欠乏症 サンプル 血液 尿 エンドユーザー 診断ラボラトリー 専門クリニック 病院 地域別 北アメリカ ラテンアメリカ ヨーロッパ 南アジア 東アジア オセアニア 中東・アフリカ 報告書に記載されている主な質問 今後数年間、新生児メタボリックスクリーニングで最も収益性の高い市場を維持し続けるのはどの地域か？ トレンドの変化は市場にどのような影響を与えるか？ COVID-19危機は市場の成長にどのような影響を与えたか？ 市場参加者はどのようにして先進地域の低空飛行の機会を捕らえることができるのか？ 市場におけるステークホルダーの戦略はどのようなものですか？ 投資家が認識する必要があり、市場への投資中に取り組む可能性がある抑制要因は何か？ 市場に影響を与える開発トレンドは何か？ 新生児メタボリックスクリーニング市場の企業は、どのようにして先進国および新興国の成長機会を利用することができますか？ 調査方法 Persistence Market Research社の調査では、新生児代謝スクリーニング市場の成長に関する広範な調査を実施し、市場の将来の成長パラメータに関する結論に到達するために、独自の調査手法を利用しています。この調査方法は、一次調査と二次調査を組み合わせたもので、アナリストが結論の正確性と信頼性を確保するのに役立ちます。 市場調査作成時にアナリストが参照した二次資料には、政府機関の統計、業界誌、白書、社内外の独自データベースなどがあります。アナリストは一次資料として、本レポートの作成に貢献したシニアマネージャー、製品ポートフォリオマネージャー、CEO、副社長、マーケティング/プロダクトマネージャー、マーケットインテリジェンスマネージャーにインタビューを行いました。 一次および二次リソースから取得した包括的な情報は、市場の企業からの検証として機能し、新生児代謝スクリーニング市場の成長見通しに関するPersistence Market Researchの予測はより正確で信頼できるものとなっています。 目次1. Executive Summary1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply-Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Development/Innovation Trends 4. Key Success Factors 4.1. Service Adoption / Usage Analysis 4.2. New Product Launches 4.3. Value chain Analysis 4.4. PESTEL Analysis 4.5. Porter’s Analysis 4.6. Key Promotional Strategies, By Key Manufacturers 4.7. Regulatory Landscape 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Expenditure 5.1.3. Global Metabolic Screening Market Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Increasing End User Facilities 5.2.2. New-Born Metabolic Screening Penetration Rate 5.2.3. Key Players Historical Growth 5.2.4. Newborn Metabolic Screening Adoption Across Regions 5.2.5. New-Born Metabolic Screening Test Cost 5.2.6. Technological Advancements 5.2.7. Regulatory Impositions 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis – Impact Assessment 6.1. COVID-19 and Impact Analysis 6.1.1. By Test 6.1.2. By Sample 6.1.3. By End User 6.1.4. By Region 6.2. 2022 Market Scenario 7. Global New-Born Metabolic Screening Market Demand Volume (Units) Analysis 2015–2022 and Forecast, 2023–2033 7.1. Historical Market Volume (Units) Analysis, 2015–2022 7.2. Current and Future Market Volume (Units) Projections, 2023–2033 7.2.1. Y-o-Y Growth Trend Analysis 8. Global New-Born Metabolic Screening Market Demand Pricing Analysis 2015–2022 and Forecast, 2023–2033 8.1. Regional Pricing Analysis 8.2. Pricing Break-up 8.2.1. Manufacturer Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 9. Global New-Born Metabolic Screening Market Demand Value or Size (US$ Mn) Analysis 2015 – 2022 and Forecast, 2023–2033 9.1. Historical Market Value (US$ Mn) Analysis, 2015 – 2022 9.2. Current and Future Market Value (US$ Mn) Projections, 2023–2033 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global New-Born Metabolic Screening Market Analysis 2015– 2022 and Forecast 2023–2033, By Test 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Test, 2015 – 2022 10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Test, 2023–2033 10.3.1. Galactosemia 10.3.2. Sickle Cell Disease 10.3.3. Cystic Fibrosis 10.3.4. Toxoplasmosis 10.3.5. Phenylketonuria (PKU) 10.3.6. Methylmalonic Acidemia 10.3.7. Maple Syrup Urine Disease (MSUD) 10.3.8. Tyrosinemia 10.3.9. Citrullinemia 10.3.10. Medium Chain Acyl CoA Dehydrogenase (MCAD) Deficiency 10.4. Market Attractiveness Analysis By Test 11. Global New-Born Metabolic Screening Market Analysis 2015– 2022 and Forecast 2023–2033, By Sample 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) By Sample, 2015 – 2022 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Sample, 2023–2033 11.3.1. Blood 11.3.2. Urine 11.4. Market Attractiveness Analysis By Sample 12. Global New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033, By End User 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) By End User, 2015 – 2022 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2023–2033 12.3.1. Diagnostic Laboratories 12.3.2. Specialty Clinics 12.3.3. Hospitals 12.4. Market Attractiveness Analysis By End User 13. Global New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033, By Region 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis by Region, 2015 – 2022 13.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Region, 2023–2033 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. South Asia 13.3.5. East Asia 13.3.6. Oceania 13.3.7. Middle East and Africa (MEA) 13.4. Market Attractiveness Analysis By Region 14. North America New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Trend Analysis by Market Taxonomy, 2015 – 2022 14.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023–2033 14.3.1. By Country 14.3.1.1. U.S. 14.3.1.2. Canada 14.3.2. By Test 14.3.3. By Sample 14.3.4. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Test 14.4.3. By Sample 14.4.4. By End User 14.5. Market Trends 14.6. Key Market Participants - Intensity Mapping 14.7. Drivers and Restraints - Impact Analysis 14.8. Country Level Analysis & Forecast 14.8.1. U.S. New-Born Metabolic Screening Market Analysis 14.8.1.1. Introduction 14.8.1.2. Market Analysis and Forecast by Market Taxonomy 14.8.1.2.1. By Test 14.8.1.2.2. By Sample 14.8.1.2.3. By End User 14.8.2. Canada New-Born Metabolic Screening Market Analysis 14.8.2.1. Introduction 14.8.2.2. Market Analysis and Forecast by Market Taxonomy 14.8.2.2.1. By Test 14.8.2.2.2. By Sample 14.8.2.2.3. By End User 15. Latin America New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis by Market Taxonomy, 2015 – 2022 15.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023–2033 15.3.1. By Country 15.3.1.1. Brazil 15.3.1.2. Mexico 15.3.1.3. Argentina 15.3.1.4. Rest of Latin America 15.3.2. By Test 15.3.3. By Sample 15.3.4. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Test 15.4.3. By Sample 15.4.4. By End User 15.5. Market Trends 15.6. Key Market Participants - Intensity Mapping 15.7. Drivers and Restraints - Impact Analysis 15.8. Country Level Analysis & Forecast 15.8.1. Brazil New-Born Metabolic Screening Market Analysis 15.8.1.1. Introduction 15.8.1.2. Market Analysis and Forecast by Market Taxonomy 15.8.1.2.1. By Test 15.8.1.2.2. By Sample 15.8.1.2.3. By End User 15.8.2. Mexico New-Born Metabolic Screening Market Analysis 15.8.2.1. Introduction 15.8.2.2. Market Analysis and Forecast by Market Taxonomy 15.8.2.2.1. By Test 15.8.2.2.2. By Sample 15.8.2.2.3. By End User 15.8.3. Argentina New-Born Metabolic Screening Market Analysis 15.8.3.1. Introduction 15.8.3.2. Market Analysis and Forecast by Market Taxonomy 15.8.3.2.1. By Test 15.8.3.2.2. By Sample 15.8.3.2.3. By End User 16. Europe New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis by Market Taxonomy, 2015 – 2022 16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023–2033 16.3.1. By Country 16.3.1.1. Germany 16.3.1.2. Italy 16.3.1.3. France 16.3.1.4. U.K. 16.3.1.5. Spain 16.3.1.6. BENELUX 16.3.1.7. Russia 16.3.1.8. Rest of Europe 16.3.2. By Test 16.3.3. By Sample 16.3.4. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Test 16.4.3. By Sample 16.4.4. By End User 16.5. Market Trends 16.6. Key Market Participants - Intensity Mapping 16.7. Drivers and Restraints - Impact Analysis 16.8. Country Level Analysis & Forecast 16.8.1. Germany New-Born Metabolic Screening Market Analysis 16.8.1.1. Introduction 16.8.1.2. Market Analysis and Forecast by Market Taxonomy 16.8.1.2.1. By Test 16.8.1.2.2. By Sample 16.8.1.2.3. By End User 16.8.2. Italy New-Born Metabolic Screening Market Analysis 16.8.2.1. Introduction 16.8.2.2. Market Analysis and Forecast by Market Taxonomy 16.8.2.2.1. By Test 16.8.2.2.2. By Sample 16.8.2.2.3. By End User 16.8.3. France New-Born Metabolic Screening Market Analysis 16.8.3.1. Introduction 16.8.3.2. Market Analysis and Forecast by Market Taxonomy 16.8.3.2.1. By Test 16.8.3.2.2. By Sample 16.8.3.2.3. By End User 16.8.4. U.K. New-Born Metabolic Screening Market Analysis 16.8.4.1. Introduction 16.8.4.2. Market Analysis and Forecast by Market Taxonomy 16.8.4.2.1. By Test 16.8.4.2.2. By Sample 16.8.4.2.3. By End User 16.8.5. Spain New-Born Metabolic Screening Market Analysis 16.8.5.1. Introduction 16.8.5.2. Market Analysis and Forecast by Market Taxonomy 16.8.5.2.1. By Test 16.8.5.2.2. By Sample 16.8.5.2.3. By End User 16.8.6. BENELUX New-Born Metabolic Screening Market Analysis 16.8.6.1. Introduction 16.8.6.2. Market Analysis and Forecast by Market Taxonomy 16.8.6.2.1. By Test 16.8.6.2.2. By Sample 16.8.6.2.3. By End User 16.8.7. Russia New-Born Metabolic Screening Market Analysis 16.8.7.1. Introduction 16.8.7.2. Market Analysis and Forecast by Market Taxonomy 16.8.7.2.1. By Test 16.8.7.2.2. By Sample 16.8.7.2.3. By End User 17. South Asia New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis by Market Taxonomy, 2015 – 2022 17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023–2033 17.3.1. By Country 17.3.1.1. India 17.3.1.2. Indonesia 17.3.1.3. Thailand 17.3.1.4. Malaysia 17.3.1.5. Rest of South Asia 17.3.2. By Test 17.3.3. By Sample 17.3.4. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Test 17.4.3. By Sample 17.4.4. By End User 17.5. Market Trends 17.6. Key Market Participants - Intensity Mapping 17.7. Drivers and Restraints - Impact Analysis 17.8. Country Level Analysis & Forecast 17.8.1. India New-Born Metabolic Screening Market Analysis 17.8.1.1. Introduction 17.8.1.2. Market Analysis and Forecast by Market Taxonomy 17.8.1.2.1. By Test 17.8.1.2.2. By Sample 17.8.1.2.3. By End User 17.8.2. Indonesia New-Born Metabolic Screening Market Analysis 17.8.2.1. Introduction 17.8.2.2. Market Analysis and Forecast by Market Taxonomy 17.8.2.2.1. By Test 17.8.2.2.2. By Sample 17.8.2.2.3. By End User 17.8.3. Thailand New-Born Metabolic Screening Market Analysis 17.8.3.1. Introduction 17.8.3.2. Market Analysis and Forecast by Market Taxonomy 17.8.3.2.1. By Test 17.8.3.2.2. By Sample 17.8.3.2.3. By End User 17.8.4. Malaysia New-Born Metabolic Screening Market Analysis 17.8.4.1. Introduction 17.8.4.2. Market Analysis and Forecast by Market Taxonomy 17.8.4.2.1. By Test 17.8.4.2.2. By Sample 17.8.4.2.3. By End User 18. East Asia New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis by Market Taxonomy, 2015 – 2022 18.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023–2033 18.3.1. By Country 18.3.1.1. China 18.3.1.2. Japan 18.3.1.3. South Korea 18.3.2. By Test 18.3.3. By Sample 18.3.4. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Test 18.4.3. By Sample 18.4.4. By End User 18.5. Market Trends 18.6. Key Market Participants - Intensity Mapping 18.7. Drivers and Restraints - Impact Analysis 18.8. Country Level Analysis & Forecast 18.8.1. China New-Born Metabolic Screening Market Analysis 18.8.1.1. Introduction 18.8.1.2. Market Analysis and Forecast by Market Taxonomy 18.8.1.2.1. By Test 18.8.1.2.2. By Sample 18.8.1.2.3. By End User 18.8.2. Japan New-Born Metabolic Screening Market Analysis 18.8.2.1. Introduction 18.8.2.2. Market Analysis and Forecast by Market Taxonomy 18.8.2.2.1. By Test 18.8.2.2.2. By Sample 18.8.2.2.3. By End User 18.8.3. South Korea New-Born Metabolic Screening Market Analysis 18.8.3.1. Introduction 18.8.3.2. Market Analysis and Forecast by Market Taxonomy 18.8.3.2.1. By Test 18.8.3.2.2. By Sample 18.8.3.2.3. By End User 19. Oceania New-Born Metabolic Screening Market 2015-2022 and Forecast 2023-2033 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis by Market Taxonomy, 2015 – 2022 19.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023–2033 19.3.1. By Country 19.3.1.1. Australia 19.3.1.2. New Zealand 19.3.2. By Test 19.3.3. By Sample 19.3.4. By End User 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Test 19.4.3. By Sample 19.4.4. By End User 19.5. Market Trends 19.6. Key Market Participants - Intensity Mapping 19.7. Drivers and Restraints - Impact Analysis 19.8. Country Level Analysis & Forecast 19.8.1. Australia New-Born Metabolic Screening Market Analysis 19.8.1.1. Introduction 19.8.1.2. Market Analysis and Forecast by Market Taxonomy 19.8.1.2.1. By Test 19.8.1.2.2. By Sample 19.8.1.2.3. By End User 19.8.2. New Zealand New-Born Metabolic Screening Market Analysis 19.8.2.1. Introduction 19.8.2.2. Market Analysis and Forecast by Market Taxonomy 19.8.2.2.1. By Test 19.8.2.2.2. By Sample 19.8.2.2.3. By End User 20. Middle East and Africa (MEA) New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033 20.1. Introduction 20.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis by Market Taxonomy, 2015 – 2022 20.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023–2033 20.3.1. By Country 20.3.1.1. GCC Countries 20.3.1.2. Turkey 20.3.1.3. South Africa 20.3.1.4. North Africa 20.3.1.5. Rest of Middle East and Africa 20.3.2. By Test 20.3.3. By Sample 20.3.4. By End User 20.4. Market Attractiveness Analysis 20.4.1. By Country 20.4.2. By Test 20.4.3. By Sample 20.4.4. By End User 20.5. Market Trends 20.6. Key Market Participants - Intensity Mapping 20.7. Drivers and Restraints - Impact Analysis 20.8. Country Level Analysis & Forecast 20.8.1. GCC Countries New-Born Metabolic Screening Market Analysis 20.8.1.1. Introduction 20.8.1.2. Market Analysis and Forecast by Market Taxonomy 20.8.1.2.1. By Test 20.8.1.2.2. By Sample 20.8.1.2.3. By End User 20.8.2. Turkey New-Born Metabolic Screening Market Analysis 20.8.2.1. Introduction 20.8.2.2. Market Analysis and Forecast by Market Taxonomy 20.8.2.2.1. By Test 20.8.2.2.2. By Sample 20.8.2.2.3. By End User 20.8.3. South Africa New-Born Metabolic Screening Market Analysis 20.8.3.1. Introduction 20.8.3.2. Market Analysis and Forecast by Market Taxonomy 20.8.3.2.1. By Test 20.8.3.2.2. By Sample 20.8.3.2.3. By End User 20.8.4. North Africa New-Born Metabolic Screening Market Analysis 20.8.4.1. Introduction 20.8.4.2. Market Analysis and Forecast by Market Taxonomy 20.8.4.2.1. By Test 20.8.4.2.2. By Sample 20.8.4.2.3. By End User 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Share Analysis of Top Players (%) 21.3. Market Presence Analysis 21.3.1. By Regional Footprint of Players 21.3.2. Product Footprint of Players 21.3.3. Channel Footprint of Players 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep Dive 22.3.1. PerkinElmer 22.3.1.1. Overview 22.3.1.2. Product & Services Portfolio 22.3.1.3. Key Financials 22.3.1.4. SWOT Analysis 22.3.1.5. Key Developments 22.3.1.6. Sales Footprint 22.3.1.7. Strategy Overview 22.3.1.7.1. Marketing Strategy 22.3.1.7.2. Product Strategy 22.3.1.7.3. Channel Strategy 22.3.2. Bio-Rad Laboratories 22.3.2.1. Overview 22.3.2.2. Product & Services Portfolio 22.3.2.3. Key Financials 22.3.2.4. SWOT Analysis 22.3.2.5. Key Developments 22.3.2.6. Sales Footprint 22.3.2.7. Strategy Overview 22.3.2.7.1. Marketing Strategy 22.3.2.7.2. Product Strategy 22.3.2.7.3. Channel Strategy 22.3.3. Trivitron Healthcare Private Limited 22.3.3.1. Overview 22.3.3.2. Product & Services Portfolio 22.3.3.3. Key Financials 22.3.3.4. SWOT Analysis 22.3.3.5. Key Developments 22.3.3.6. Sales Footprint 22.3.3.7. Strategy Overview 22.3.3.7.1. Marketing Strategy 22.3.3.7.2. Product Strategy 22.3.3.7.3. Channel Strategy 22.3.4. BioMedomics, Inc. 22.3.4.1. Overview 22.3.4.2. Product & Services Portfolio 22.3.4.3. Key Financials 22.3.4.4. SWOT Analysis 22.3.4.5. Key Developments 22.3.4.6. Sales Footprint 22.3.4.7. Strategy Overview 22.3.4.7.1. Marketing Strategy 22.3.4.7.2. Product Strategy 22.3.4.7.3. Channel Strategy 22.3.5. Luminex Corporation 22.3.5.1. Overview 22.3.5.2. Product & Services Portfolio 22.3.5.3. Key Financials 22.3.5.4. SWOT Analysis 22.3.5.5. Key Developments 22.3.5.6. Sales Footprint 22.3.5.7. Strategy Overview 22.3.5.7.1. Marketing Strategy 22.3.5.7.2. Product Strategy 22.3.5.7.3. Channel Strategy 22.3.6. MP BIOMEDICALS 22.3.6.1. Overview 22.3.6.2. Product & Services Portfolio 22.3.6.3. Key Financials 22.3.6.4. SWOT Analysis 22.3.6.5. Key Developments 22.3.6.6. Sales Footprint 22.3.6.7. Strategy Overview 22.3.6.7.1. Marketing Strategy 22.3.6.7.2. Product Strategy 22.3.6.7.3. Channel Strategy 22.3.7. Synergy Medical Systems LLP 22.3.7.1. Overview 22.3.7.2. Product & Services Portfolio 22.3.7.3. Key Financials 22.3.7.4. SWOT Analysis 22.3.7.5. Key Developments 22.3.7.6. Sales Footprint 22.3.7.7. Strategy Overview 22.3.7.7.1. Marketing Strategy 22.3.7.7.2. Product Strategy 22.3.7.7.3. Channel Strategy 22.3.8. Agilent Technologies, Inc 22.3.8.1. Overview 22.3.8.2. Product & Services Portfolio 22.3.8.3. Key Financials 22.3.8.4. SWOT Analysis 22.3.8.5. Key Developments 22.3.8.6. Sales Footprint 22.3.8.7. Strategy Overview 22.3.8.7.1. Marketing Strategy 22.3.8.7.2. Product Strategy 22.3.8.7.3. Channel Strategy 22.3.9. Thermo Fisher Scientific, Inc 22.3.9.1. Overview 22.3.9.2. Product & Services Portfolio 22.3.9.3. Key Financials 22.3.9.4. SWOT Analysis 22.3.9.5. Key Developments 22.3.9.6. Sales Footprint 22.3.9.7. Strategy Overview 22.3.9.7.1. Marketing Strategy 22.3.9.7.2. Product Strategy 22.3.9.7.3. Channel Strategy 22.3.10. Zivak Technologies 22.3.10.1. Overview 22.3.10.2. Product & Services Portfolio 22.3.10.3. Key Financials 22.3.10.4. SWOT Analysis 22.3.10.5. Key Developments 22.3.10.6. Sales Footprint 22.3.10.7. Strategy Overview 22.3.10.7.1. Marketing Strategy 22.3.10.7.2. Product Strategy 22.3.10.7.3. Channel Strategy 22.3.11. Covidien Plc 22.3.11.1. Overview 22.3.11.2. Product & Services Portfolio 22.3.11.3. Key Financials 22.3.11.4. SWOT Analysis 22.3.11.5. Key Developments 22.3.11.6. Sales Footprint 22.3.11.7. Strategy Overview 22.3.11.7.1. Marketing Strategy 22.3.11.7.2. Product Strategy 22.3.11.7.3. Channel Strategy 22.3.12. AB Sciex LLC 22.3.12.1. Overview 22.3.12.2. Product & Services Portfolio 22.3.12.3. Key Financials 22.3.12.4. SWOT Analysis 22.3.12.5. Key Developments 22.3.12.6. Sales Footprint 22.3.12.7. Strategy Overview 22.3.12.7.1. Marketing Strategy 22.3.12.7.2. Product Strategy 22.3.12.7.3. Channel Strategy 22.3.13. Waters Corp. 22.3.13.1. Overview 22.3.13.2. Product & Services Portfolio 22.3.13.3. Key Financials 22.3.13.4. SWOT Analysis 22.3.13.5. Key Developments 22.3.13.6. Sales Footprint 22.3.13.7. Strategy Overview 22.3.13.7.1. Marketing Strategy 22.3.13.7.2. Product Strategy 22.3.13.7.3. Channel Strategy 22.3.14. Masimo Corp. 22.3.14.1. Overview 22.3.14.2. Product & Services Portfolio 22.3.14.3. Key Financials 22.3.14.4. SWOT Analysis 22.3.14.5. Key Developments 22.3.14.6. Sales Footprint 22.3.14.7. Strategy Overview 22.3.14.7.1. Marketing Strategy 22.3.14.7.2. Product Strategy 22.3.14.7.3. Channel Strategy 22.3.15. Natus Medical Inc. 22.3.15.1. Overview 22.3.15.2. Product & Services Portfolio 22.3.15.3. Key Financials 22.3.15.4. SWOT Analysis 22.3.15.5. Key Developments 22.3.15.6. Sales Footprint 22.3.15.7. Strategy Overview 22.3.15.7.1. Marketing Strategy 22.3.15.7.2. Product Strategy 22.3.15.7.3. Channel Strategy 23. Assumptions and Acronyms Used 24. Research Methodology
SummaryGlobal New-Born Metabolic Screening Market: Scope of the Report Table of Contents1. Executive Summary1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply-Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Development/Innovation Trends 4. Key Success Factors 4.1. Service Adoption / Usage Analysis 4.2. New Product Launches 4.3. Value chain Analysis 4.4. PESTEL Analysis 4.5. Porter’s Analysis 4.6. Key Promotional Strategies, By Key Manufacturers 4.7. Regulatory Landscape 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Expenditure 5.1.3. Global Metabolic Screening Market Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Increasing End User Facilities 5.2.2. New-Born Metabolic Screening Penetration Rate 5.2.3. Key Players Historical Growth 5.2.4. Newborn Metabolic Screening Adoption Across Regions 5.2.5. New-Born Metabolic Screening Test Cost 5.2.6. Technological Advancements 5.2.7. Regulatory Impositions 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis – Impact Assessment 6.1. COVID-19 and Impact Analysis 6.1.1. By Test 6.1.2. By Sample 6.1.3. By End User 6.1.4. By Region 6.2. 2022 Market Scenario 7. Global New-Born Metabolic Screening Market Demand Volume (Units) Analysis 2015–2022 and Forecast, 2023–2033 7.1. Historical Market Volume (Units) Analysis, 2015–2022 7.2. Current and Future Market Volume (Units) Projections, 2023–2033 7.2.1. Y-o-Y Growth Trend Analysis 8. Global New-Born Metabolic Screening Market Demand Pricing Analysis 2015–2022 and Forecast, 2023–2033 8.1. Regional Pricing Analysis 8.2. Pricing Break-up 8.2.1. Manufacturer Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 9. Global New-Born Metabolic Screening Market Demand Value or Size (US$ Mn) Analysis 2015 – 2022 and Forecast, 2023–2033 9.1. Historical Market Value (US$ Mn) Analysis, 2015 – 2022 9.2. Current and Future Market Value (US$ Mn) Projections, 2023–2033 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global New-Born Metabolic Screening Market Analysis 2015– 2022 and Forecast 2023–2033, By Test 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Test, 2015 – 2022 10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Test, 2023–2033 10.3.1. Galactosemia 10.3.2. Sickle Cell Disease 10.3.3. Cystic Fibrosis 10.3.4. Toxoplasmosis 10.3.5. Phenylketonuria (PKU) 10.3.6. Methylmalonic Acidemia 10.3.7. Maple Syrup Urine Disease (MSUD) 10.3.8. Tyrosinemia 10.3.9. Citrullinemia 10.3.10. Medium Chain Acyl CoA Dehydrogenase (MCAD) Deficiency 10.4. Market Attractiveness Analysis By Test 11. Global New-Born Metabolic Screening Market Analysis 2015– 2022 and Forecast 2023–2033, By Sample 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) By Sample, 2015 – 2022 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Sample, 2023–2033 11.3.1. Blood 11.3.2. Urine 11.4. Market Attractiveness Analysis By Sample 12. Global New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033, By End User 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) By End User, 2015 – 2022 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2023–2033 12.3.1. Diagnostic Laboratories 12.3.2. Specialty Clinics 12.3.3. Hospitals 12.4. Market Attractiveness Analysis By End User 13. Global New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033, By Region 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis by Region, 2015 – 2022 13.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Region, 2023–2033 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. South Asia 13.3.5. East Asia 13.3.6. Oceania 13.3.7. Middle East and Africa (MEA) 13.4. Market Attractiveness Analysis By Region 14. North America New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Trend Analysis by Market Taxonomy, 2015 – 2022 14.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023–2033 14.3.1. By Country 14.3.1.1. U.S. 14.3.1.2. Canada 14.3.2. By Test 14.3.3. By Sample 14.3.4. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Test 14.4.3. By Sample 14.4.4. By End User 14.5. Market Trends 14.6. Key Market Participants - Intensity Mapping 14.7. Drivers and Restraints - Impact Analysis 14.8. Country Level Analysis & Forecast 14.8.1. U.S. New-Born Metabolic Screening Market Analysis 14.8.1.1. Introduction 14.8.1.2. Market Analysis and Forecast by Market Taxonomy 14.8.1.2.1. By Test 14.8.1.2.2. By Sample 14.8.1.2.3. By End User 14.8.2. Canada New-Born Metabolic Screening Market Analysis 14.8.2.1. Introduction 14.8.2.2. Market Analysis and Forecast by Market Taxonomy 14.8.2.2.1. By Test 14.8.2.2.2. By Sample 14.8.2.2.3. By End User 15. Latin America New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis by Market Taxonomy, 2015 – 2022 15.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023–2033 15.3.1. By Country 15.3.1.1. Brazil 15.3.1.2. Mexico 15.3.1.3. Argentina 15.3.1.4. Rest of Latin America 15.3.2. By Test 15.3.3. By Sample 15.3.4. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Test 15.4.3. By Sample 15.4.4. By End User 15.5. Market Trends 15.6. Key Market Participants - Intensity Mapping 15.7. Drivers and Restraints - Impact Analysis 15.8. Country Level Analysis & Forecast 15.8.1. Brazil New-Born Metabolic Screening Market Analysis 15.8.1.1. Introduction 15.8.1.2. Market Analysis and Forecast by Market Taxonomy 15.8.1.2.1. By Test 15.8.1.2.2. By Sample 15.8.1.2.3. By End User 15.8.2. Mexico New-Born Metabolic Screening Market Analysis 15.8.2.1. Introduction 15.8.2.2. Market Analysis and Forecast by Market Taxonomy 15.8.2.2.1. By Test 15.8.2.2.2. By Sample 15.8.2.2.3. By End User 15.8.3. Argentina New-Born Metabolic Screening Market Analysis 15.8.3.1. Introduction 15.8.3.2. Market Analysis and Forecast by Market Taxonomy 15.8.3.2.1. By Test 15.8.3.2.2. By Sample 15.8.3.2.3. By End User 16. Europe New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis by Market Taxonomy, 2015 – 2022 16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023–2033 16.3.1. By Country 16.3.1.1. Germany 16.3.1.2. Italy 16.3.1.3. France 16.3.1.4. U.K. 16.3.1.5. Spain 16.3.1.6. BENELUX 16.3.1.7. Russia 16.3.1.8. Rest of Europe 16.3.2. By Test 16.3.3. By Sample 16.3.4. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Test 16.4.3. By Sample 16.4.4. By End User 16.5. Market Trends 16.6. Key Market Participants - Intensity Mapping 16.7. Drivers and Restraints - Impact Analysis 16.8. Country Level Analysis & Forecast 16.8.1. Germany New-Born Metabolic Screening Market Analysis 16.8.1.1. Introduction 16.8.1.2. Market Analysis and Forecast by Market Taxonomy 16.8.1.2.1. By Test 16.8.1.2.2. By Sample 16.8.1.2.3. By End User 16.8.2. Italy New-Born Metabolic Screening Market Analysis 16.8.2.1. Introduction 16.8.2.2. Market Analysis and Forecast by Market Taxonomy 16.8.2.2.1. By Test 16.8.2.2.2. By Sample 16.8.2.2.3. By End User 16.8.3. France New-Born Metabolic Screening Market Analysis 16.8.3.1. Introduction 16.8.3.2. Market Analysis and Forecast by Market Taxonomy 16.8.3.2.1. By Test 16.8.3.2.2. By Sample 16.8.3.2.3. By End User 16.8.4. U.K. New-Born Metabolic Screening Market Analysis 16.8.4.1. Introduction 16.8.4.2. Market Analysis and Forecast by Market Taxonomy 16.8.4.2.1. By Test 16.8.4.2.2. By Sample 16.8.4.2.3. By End User 16.8.5. Spain New-Born Metabolic Screening Market Analysis 16.8.5.1. Introduction 16.8.5.2. Market Analysis and Forecast by Market Taxonomy 16.8.5.2.1. By Test 16.8.5.2.2. By Sample 16.8.5.2.3. By End User 16.8.6. BENELUX New-Born Metabolic Screening Market Analysis 16.8.6.1. Introduction 16.8.6.2. Market Analysis and Forecast by Market Taxonomy 16.8.6.2.1. By Test 16.8.6.2.2. By Sample 16.8.6.2.3. By End User 16.8.7. Russia New-Born Metabolic Screening Market Analysis 16.8.7.1. Introduction 16.8.7.2. Market Analysis and Forecast by Market Taxonomy 16.8.7.2.1. By Test 16.8.7.2.2. By Sample 16.8.7.2.3. By End User 17. South Asia New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis by Market Taxonomy, 2015 – 2022 17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023–2033 17.3.1. By Country 17.3.1.1. India 17.3.1.2. Indonesia 17.3.1.3. Thailand 17.3.1.4. Malaysia 17.3.1.5. Rest of South Asia 17.3.2. By Test 17.3.3. By Sample 17.3.4. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Test 17.4.3. By Sample 17.4.4. By End User 17.5. Market Trends 17.6. Key Market Participants - Intensity Mapping 17.7. Drivers and Restraints - Impact Analysis 17.8. Country Level Analysis & Forecast 17.8.1. India New-Born Metabolic Screening Market Analysis 17.8.1.1. Introduction 17.8.1.2. Market Analysis and Forecast by Market Taxonomy 17.8.1.2.1. By Test 17.8.1.2.2. By Sample 17.8.1.2.3. By End User 17.8.2. Indonesia New-Born Metabolic Screening Market Analysis 17.8.2.1. Introduction 17.8.2.2. Market Analysis and Forecast by Market Taxonomy 17.8.2.2.1. By Test 17.8.2.2.2. By Sample 17.8.2.2.3. By End User 17.8.3. Thailand New-Born Metabolic Screening Market Analysis 17.8.3.1. Introduction 17.8.3.2. Market Analysis and Forecast by Market Taxonomy 17.8.3.2.1. By Test 17.8.3.2.2. By Sample 17.8.3.2.3. By End User 17.8.4. Malaysia New-Born Metabolic Screening Market Analysis 17.8.4.1. Introduction 17.8.4.2. Market Analysis and Forecast by Market Taxonomy 17.8.4.2.1. By Test 17.8.4.2.2. By Sample 17.8.4.2.3. By End User 18. East Asia New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis by Market Taxonomy, 2015 – 2022 18.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023–2033 18.3.1. By Country 18.3.1.1. China 18.3.1.2. Japan 18.3.1.3. South Korea 18.3.2. By Test 18.3.3. By Sample 18.3.4. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Test 18.4.3. By Sample 18.4.4. By End User 18.5. Market Trends 18.6. Key Market Participants - Intensity Mapping 18.7. Drivers and Restraints - Impact Analysis 18.8. Country Level Analysis & Forecast 18.8.1. China New-Born Metabolic Screening Market Analysis 18.8.1.1. Introduction 18.8.1.2. Market Analysis and Forecast by Market Taxonomy 18.8.1.2.1. By Test 18.8.1.2.2. By Sample 18.8.1.2.3. By End User 18.8.2. Japan New-Born Metabolic Screening Market Analysis 18.8.2.1. Introduction 18.8.2.2. Market Analysis and Forecast by Market Taxonomy 18.8.2.2.1. By Test 18.8.2.2.2. By Sample 18.8.2.2.3. By End User 18.8.3. South Korea New-Born Metabolic Screening Market Analysis 18.8.3.1. Introduction 18.8.3.2. Market Analysis and Forecast by Market Taxonomy 18.8.3.2.1. By Test 18.8.3.2.2. By Sample 18.8.3.2.3. By End User 19. Oceania New-Born Metabolic Screening Market 2015-2022 and Forecast 2023-2033 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis by Market Taxonomy, 2015 – 2022 19.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023–2033 19.3.1. By Country 19.3.1.1. Australia 19.3.1.2. New Zealand 19.3.2. By Test 19.3.3. By Sample 19.3.4. By End User 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Test 19.4.3. By Sample 19.4.4. By End User 19.5. Market Trends 19.6. Key Market Participants - Intensity Mapping 19.7. Drivers and Restraints - Impact Analysis 19.8. Country Level Analysis & Forecast 19.8.1. Australia New-Born Metabolic Screening Market Analysis 19.8.1.1. Introduction 19.8.1.2. Market Analysis and Forecast by Market Taxonomy 19.8.1.2.1. By Test 19.8.1.2.2. By Sample 19.8.1.2.3. By End User 19.8.2. New Zealand New-Born Metabolic Screening Market Analysis 19.8.2.1. Introduction 19.8.2.2. Market Analysis and Forecast by Market Taxonomy 19.8.2.2.1. By Test 19.8.2.2.2. By Sample 19.8.2.2.3. By End User 20. Middle East and Africa (MEA) New-Born Metabolic Screening Market Analysis 2015 – 2022 and Forecast 2023–2033 20.1. Introduction 20.2. Historical Market Size (US$ Mn) Trend and Volume (Units) Analysis by Market Taxonomy, 2015 – 2022 20.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023–2033 20.3.1. By Country 20.3.1.1. GCC Countries 20.3.1.2. Turkey 20.3.1.3. South Africa 20.3.1.4. North Africa 20.3.1.5. Rest of Middle East and Africa 20.3.2. By Test 20.3.3. By Sample 20.3.4. By End User 20.4. Market Attractiveness Analysis 20.4.1. By Country 20.4.2. By Test 20.4.3. By Sample 20.4.4. By End User 20.5. Market Trends 20.6. Key Market Participants - Intensity Mapping 20.7. Drivers and Restraints - Impact Analysis 20.8. Country Level Analysis & Forecast 20.8.1. GCC Countries New-Born Metabolic Screening Market Analysis 20.8.1.1. Introduction 20.8.1.2. Market Analysis and Forecast by Market Taxonomy 20.8.1.2.1. By Test 20.8.1.2.2. By Sample 20.8.1.2.3. By End User 20.8.2. Turkey New-Born Metabolic Screening Market Analysis 20.8.2.1. Introduction 20.8.2.2. Market Analysis and Forecast by Market Taxonomy 20.8.2.2.1. By Test 20.8.2.2.2. By Sample 20.8.2.2.3. By End User 20.8.3. South Africa New-Born Metabolic Screening Market Analysis 20.8.3.1. Introduction 20.8.3.2. Market Analysis and Forecast by Market Taxonomy 20.8.3.2.1. By Test 20.8.3.2.2. By Sample 20.8.3.2.3. By End User 20.8.4. North Africa New-Born Metabolic Screening Market Analysis 20.8.4.1. Introduction 20.8.4.2. Market Analysis and Forecast by Market Taxonomy 20.8.4.2.1. By Test 20.8.4.2.2. By Sample 20.8.4.2.3. By End User 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Share Analysis of Top Players (%) 21.3. Market Presence Analysis 21.3.1. By Regional Footprint of Players 21.3.2. Product Footprint of Players 21.3.3. Channel Footprint of Players 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep Dive 22.3.1. PerkinElmer 22.3.1.1. Overview 22.3.1.2. Product & Services Portfolio 22.3.1.3. Key Financials 22.3.1.4. SWOT Analysis 22.3.1.5. Key Developments 22.3.1.6. Sales Footprint 22.3.1.7. Strategy Overview 22.3.1.7.1. Marketing Strategy 22.3.1.7.2. Product Strategy 22.3.1.7.3. Channel Strategy 22.3.2. Bio-Rad Laboratories 22.3.2.1. Overview 22.3.2.2. Product & Services Portfolio 22.3.2.3. Key Financials 22.3.2.4. SWOT Analysis 22.3.2.5. Key Developments 22.3.2.6. Sales Footprint 22.3.2.7. Strategy Overview 22.3.2.7.1. Marketing Strategy 22.3.2.7.2. Product Strategy 22.3.2.7.3. Channel Strategy 22.3.3. Trivitron Healthcare Private Limited 22.3.3.1. Overview 22.3.3.2. Product & Services Portfolio 22.3.3.3. Key Financials 22.3.3.4. SWOT Analysis 22.3.3.5. Key Developments 22.3.3.6. Sales Footprint 22.3.3.7. Strategy Overview 22.3.3.7.1. Marketing Strategy 22.3.3.7.2. Product Strategy 22.3.3.7.3. Channel Strategy 22.3.4. BioMedomics, Inc. 22.3.4.1. Overview 22.3.4.2. Product & Services Portfolio 22.3.4.3. Key Financials 22.3.4.4. SWOT Analysis 22.3.4.5. Key Developments 22.3.4.6. Sales Footprint 22.3.4.7. Strategy Overview 22.3.4.7.1. Marketing Strategy 22.3.4.7.2. Product Strategy 22.3.4.7.3. Channel Strategy 22.3.5. Luminex Corporation 22.3.5.1. Overview 22.3.5.2. Product & Services Portfolio 22.3.5.3. Key Financials 22.3.5.4. SWOT Analysis 22.3.5.5. Key Developments 22.3.5.6. Sales Footprint 22.3.5.7. Strategy Overview 22.3.5.7.1. Marketing Strategy 22.3.5.7.2. Product Strategy 22.3.5.7.3. Channel Strategy 22.3.6. MP BIOMEDICALS 22.3.6.1. Overview 22.3.6.2. Product & Services Portfolio 22.3.6.3. Key Financials 22.3.6.4. SWOT Analysis 22.3.6.5. Key Developments 22.3.6.6. Sales Footprint 22.3.6.7. Strategy Overview 22.3.6.7.1. Marketing Strategy 22.3.6.7.2. Product Strategy 22.3.6.7.3. Channel Strategy 22.3.7. Synergy Medical Systems LLP 22.3.7.1. Overview 22.3.7.2. Product & Services Portfolio 22.3.7.3. Key Financials 22.3.7.4. SWOT Analysis 22.3.7.5. Key Developments 22.3.7.6. Sales Footprint 22.3.7.7. Strategy Overview 22.3.7.7.1. Marketing Strategy 22.3.7.7.2. Product Strategy 22.3.7.7.3. Channel Strategy 22.3.8. Agilent Technologies, Inc 22.3.8.1. Overview 22.3.8.2. Product & Services Portfolio 22.3.8.3. Key Financials 22.3.8.4. SWOT Analysis 22.3.8.5. Key Developments 22.3.8.6. Sales Footprint 22.3.8.7. Strategy Overview 22.3.8.7.1. Marketing Strategy 22.3.8.7.2. Product Strategy 22.3.8.7.3. Channel Strategy 22.3.9. Thermo Fisher Scientific, Inc 22.3.9.1. Overview 22.3.9.2. Product & Services Portfolio 22.3.9.3. Key Financials 22.3.9.4. SWOT Analysis 22.3.9.5. Key Developments 22.3.9.6. Sales Footprint 22.3.9.7. Strategy Overview 22.3.9.7.1. Marketing Strategy 22.3.9.7.2. Product Strategy 22.3.9.7.3. Channel Strategy 22.3.10. Zivak Technologies 22.3.10.1. Overview 22.3.10.2. Product & Services Portfolio 22.3.10.3. Key Financials 22.3.10.4. SWOT Analysis 22.3.10.5. Key Developments 22.3.10.6. Sales Footprint 22.3.10.7. Strategy Overview 22.3.10.7.1. Marketing Strategy 22.3.10.7.2. Product Strategy 22.3.10.7.3. Channel Strategy 22.3.11. Covidien Plc 22.3.11.1. Overview 22.3.11.2. Product & Services Portfolio 22.3.11.3. Key Financials 22.3.11.4. SWOT Analysis 22.3.11.5. Key Developments 22.3.11.6. Sales Footprint 22.3.11.7. Strategy Overview 22.3.11.7.1. Marketing Strategy 22.3.11.7.2. Product Strategy 22.3.11.7.3. Channel Strategy 22.3.12. AB Sciex LLC 22.3.12.1. Overview 22.3.12.2. Product & Services Portfolio 22.3.12.3. Key Financials 22.3.12.4. SWOT Analysis 22.3.12.5. Key Developments 22.3.12.6. Sales Footprint 22.3.12.7. Strategy Overview 22.3.12.7.1. Marketing Strategy 22.3.12.7.2. Product Strategy 22.3.12.7.3. Channel Strategy 22.3.13. Waters Corp. 22.3.13.1. Overview 22.3.13.2. Product & Services Portfolio 22.3.13.3. Key Financials 22.3.13.4. SWOT Analysis 22.3.13.5. Key Developments 22.3.13.6. Sales Footprint 22.3.13.7. Strategy Overview 22.3.13.7.1. Marketing Strategy 22.3.13.7.2. Product Strategy 22.3.13.7.3. Channel Strategy 22.3.14. Masimo Corp. 22.3.14.1. Overview 22.3.14.2. Product & Services Portfolio 22.3.14.3. Key Financials 22.3.14.4. SWOT Analysis 22.3.14.5. Key Developments 22.3.14.6. Sales Footprint 22.3.14.7. Strategy Overview 22.3.14.7.1. Marketing Strategy 22.3.14.7.2. Product Strategy 22.3.14.7.3. Channel Strategy 22.3.15. Natus Medical Inc. 22.3.15.1. Overview 22.3.15.2. Product & Services Portfolio 22.3.15.3. Key Financials 22.3.15.4. SWOT Analysis 22.3.15.5. Key Developments 22.3.15.6. Sales Footprint 22.3.15.7. Strategy Overview 22.3.15.7.1. Marketing Strategy 22.3.15.7.2. Product Strategy 22.3.15.7.3. Channel Strategy 23. Assumptions and Acronyms Used 24. Research Methodology
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療機器）の最新刊レポート
Persistence Market Research社の医療・製薬・メディカルデバイス分野での最新刊レポート
本レポートと同じKEY WORD（）の最新刊レポート
よくあるご質問Persistence Market Research社はどのような調査会社ですか?パーシスタンスマーケットリサーチ（Persistence Market Research/PMR）は独自の方法論を用いたデータ解析と市場調査をベースに広範な産業調査報告書とカスタム調査を提供しています... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/22 10:26 155.52 円 163.34 円 198.56 円 |